4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide for treatment of melanoma

• 收藏
• 分享

专利权人:

Paul W Manley

发明人:

Paul W Manley,Georg Martiny-Baron,Juergen Mestan

申请号：

US12301690

公开号：

US08093259B2

申请日:

2007.05.23

申请国别(地区):

US

年份:

2012

代理人:

摘要：

The present invention relates to the use of pyrimidylaminobenzamide compounds for the preparation of a drug for the treatment of diseases that respond to modulation of Ephrin receptor kinase, especially EphB4, activity, especially for the curative and/or prophylactic treatment of proliferative diseases, and to a method of treating diseases that respond to modulation of kinase activity, especially Ephrin receptor kinase activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/